Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial

Medicine and Dentistry

• Patient 100%
• Heart Failure with Preserved Ejection Fraction 66%
• Heart Left Ventricle Ejection Fraction 44%
• Inpatient 33%
• Heart Failure 22%
• Mineralocorticoid Antagonist 22%
• Comorbidity 22%
• Woman 11%
• Chronic Kidney Disease 11%
• Age 11%
• Amaurosis 11%
• Diabetes 11%
• Heart 11%
• Amino Terminal Sequence 11%
• Maturity Onset Diabetes of the Young 11%
• Atrial Fibrillation 11%
• New York Heart Association Class 11%
• ACE Inhibitor 11%
• Angiotensin Receptor Antagonist 11%
• Placebo 11%
• Beta Adrenergic Receptor Blocking Agent 11%
• Natriuretic Factor 11%
• Empagliflozin 11%
• Angiotensin 11%
• Symptom 11%